TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
PDSB

PDS Biotechnology Corp

Healthcare · Biotechnology

0.91$ +8.1% vs. previous close Closing price · As of: Sep 22, 2026

Statements

Balance Sheet

PDS Biotechnology Corp (PDSB) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 8.8 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet PDSB
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
57 59 69 60 52 45 47 40 35 30 25 8.8
57 59 69 60 52 45 42 34 28 28 23 7.0
54 57 67 58 50 42 40 32 26 27 22 5.6
54 57 67 58 50 42 40 32 26 27 22 5.6
33 33 32 30 30 26 25 25 25 21 21 12
9.2 14 15 16 18 17 18 12 13 9.5 10 12
0.1 4.2 7.3 10 13 13 13 5.6 6.0 5.2 5.2 4.4
5.4 7.0 6.0 3.3 1.3 1.7 2.9 4.5 5.2 3.6 3.7 6.4
23 20 17 14 12 9.2 6.4 13 12 12 11
24 26 37 31 22 19 22 16 9.5 9.3 3.9 -3.6
-134 -145 -155 -163 -174 -182 -191 -200 -209 -217 -224 -234
31 32 35 37 37 36 41 46 47 46 55 56

Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?